Developer of oligonucleotide therapies intended to offer genetic medicines. The company helps to pair the gene-silencing nucleic acid with a targeting molecule to specific types of kidney cells, enabl...

Healthcare
Cambridge, MA, United States
Founded 2021
4 employees
Website
Valuation
$115M
Market implied
Share Price
N/A
Total Raised
$105M
Last Round
N/A

Get the full picture

Create a free account to unlock Judo Bio's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required